ADGI logo

Adagio Therapeutics (ADGI) Financials

Balance sheets

Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 1, 2021Mar 31, 2021Sep 30, 2020

Total Assets

$484.6 M(-12.9%)$556.3 M(-10.3%)$620.1 M(-9.6%)$686.3 M(+72.4%)$398.0 M(+319.5%)$94.9 M-

Current Assets

$481.4 M(-13.2%)$554.3 M(-10.1%)$616.7 M(-9.3%)$680.2 M(+71.7%)$396.1 M(+317.5%)$94.9 M-

Non Current Assets

$3.3 M(+64.9%)$2.0 M(-41.7%)$3.4 M(-44.7%)$6.1 M(+216.3%)$1.9 M(+100.0%)$0.0-

Total Liabilities

$69.8 M(-28.0%)$96.9 M(+56.1%)$62.1 M(+17.0%)$53.1 M(-90.2%)$542.6 M(+400.0%)$108.5 M-

Current Liabilities

$67.9 M(-28.9%)$95.5 M(+53.9%)$62.1 M(+17.0%)$53.0 M(+40.0%)$37.9 M(+32.1%)$28.7 M-

Long Term Liabilities

$1.9 M(+40.3%)$1.3 M(+11125.0%)$12.0 K(+50.0%)$8000.0(-100.0%)$504.7 M(+532.1%)$79.9 M-

Shareholders Equity

$414.8 M(-9.7%)$459.4 M(-17.7%)$558.0 M(-11.9%)$633.2 M(+537.8%)-$144.6 M(-959.0%)-$13.7 M-

Book Value

$414.8 M(-9.7%)$459.4 M(-17.7%)$558.0 M(-11.9%)$633.2 M(+537.8%)-$144.6 M(-39.9%)-$103.4 M-

Working Capital

$413.5 M(-9.9%)$458.8 M(-17.3%)$554.7 M(-11.6%)$627.1 M(+75.1%)$358.2 M(+441.1%)$66.2 M-

Cash And Cash Equivalents

$474.9 M(-10.8%)$532.2 M(-1.8%)$542.2 M(+13.4%)$478.3 M(+21.9%)$392.5 M(+330.2%)$91.2 M-

Accounts Payable

$14.2 M(-23.8%)$18.7 M(+223.1%)$5.8 M(-67.1%)$17.6 M(+63.9%)$10.7 M(-5.3%)$11.3 M-

Accounts Receivable

-------

Short Term Debt

$969.0 K(+207.6%)$315.0 K-----

Long Term Debt

-------

Total Debt

$969.0 K(+207.6%)$315.0 K(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

Debt To Equity

0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0-

Current Ratio

7.1(+22.2%)5.8(-41.6%)9.9(-22.5%)12.8(+22.7%)10.4(+215.7%)3.3-

Quick Ratio

-------

Inventory

-------

Retained Earnings

-------

PB Ratio

0.9(-21.1%)1.1(-24.3%)1.4(-80.6%)7.4---

Income statements

Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 1, 2021Mar 31, 2021Sep 30, 2020

EPS

-$0.5(+49.5%)-$0.9(-24.1%)-$0.7(+23.5%)-$1.0(-136.9%)-$0.4(+32.4%)-$0.6(+19.4%)-$0.8

TTM EPS

-$3.1(-1.8%)-$3.1(-11.5%)-$2.8(-37.4%)-$2.0(-12.4%)-$1.8(-30.2%)-$1.4(-80.6%)-$0.8

Revenue

-------

TTM Revenue

-------

Total Expenses

$51.7 M(-48.6%)$100.7 M(+21.2%)$83.1 M(+47.3%)$56.4 M(+33.7%)$42.2 M(+11.9%)$37.7 M(+365.9%)$8.1 M

Operating Expenses

$51.7 M(-48.6%)$100.7 M(+21.2%)$83.1 M(+47.3%)$56.4 M(+33.7%)$42.2 M(+11.9%)$37.7 M(+365.9%)$8.1 M

Cost Of Goods Sold

-------

TTM Cost Of Goods Sold

-------

Gross Profit

-------

TTM Gross Profit

-------

Gross Margin

-------

Operating Profit

-$51.7 M(+48.6%)-$100.7 M(-21.2%)-$83.1 M(-47.3%)-$56.4 M(-33.7%)-$42.2 M(-11.9%)-$37.7 M(-365.9%)-$8.1 M

TTM Operating Profit

-$292.0 M(-3.4%)-$282.4 M(-28.7%)-$219.4 M(-61.0%)-$136.3 M(-54.9%)-$88.0 M(-92.1%)-$45.8 M(-465.9%)-$8.1 M

Operating Margin

-------

Net Income

-$51.0 M(+49.4%)-$100.7 M(-21.2%)-$83.0 M(-37.5%)-$60.4 M(-35.1%)-$44.7 M(-15.4%)-$38.7 M(+19.4%)-$48.0 M

TTM Net Income

-$295.1 M(-2.2%)-$288.8 M(-27.3%)-$226.8 M(-57.8%)-$143.7 M(-9.4%)-$131.4 M(-51.5%)-$86.7 M(-80.6%)-$48.0 M

Net Margin

-------

EBIT

-$51.7 M(+48.6%)-$100.7 M(-21.2%)-$83.1 M(-47.3%)-$56.4 M(-33.7%)-$42.2 M(-11.9%)-$37.7 M(-365.9%)-$8.1 M

TTM EBIT

-$292.0 M(-3.4%)-$282.4 M(-28.7%)-$219.4 M(-61.0%)-$136.3 M(-54.9%)-$88.0 M(-92.1%)-$45.8 M(-465.9%)-$8.1 M

EBITDA

-$51.6 M(+48.7%)-$100.7 M(-21.1%)-$83.1 M(-47.3%)-$56.4 M(-33.7%)-$42.2 M(-11.9%)-$37.7 M(-365.9%)-$8.1 M

TTM EBITDA

-$291.8 M(-3.3%)-$282.4 M(-28.7%)-$219.4 M(-61.0%)-$136.3 M(-54.9%)-$88.0 M(-92.1%)-$45.8 M(-465.9%)-$8.1 M

Selling, General & Administrative Expenses

-------

TTM SGA

-------

Depreciation And Amortization

-------

TTM D&A

-------

Interest Expense

-------

TTM Interest Expense

-------

Income Tax

-------

TTM Income Tax

-------

PE Ratio

-------

PS Ratio

-------

Cashflow statements

Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 1, 2021Mar 31, 2021Sep 30, 2020

Cash From Operations

-$57.4 M(+2.8%)-$59.0 M(+19.4%)-$73.2 M(-35.0%)-$54.2 M(-61.5%)-$33.6 M(-41.4%)-$23.7 M-

TTM CFO

-$243.9 M(-10.8%)-$220.0 M(-19.1%)-$184.7 M(-65.7%)-$111.5 M(-94.6%)-$57.3 M(-141.4%)-$23.7 M-

Cash From Investing

-$17.0 K(-100.0%)$49.0 M(-64.5%)$137.9 M(+173.1%)-$188.6 M(-100.0%)$0.0(0%)$0.0-

TTM CFI

-$1.7 M(-1.0%)-$1.7 M(+96.6%)-$50.7 M(+73.1%)-$188.6 M(-100.0%)$0.0(0%)$0.0-

Cash From Financing

$74.0 K(+64.4%)$45.0 K(+106.0%)-$749.0 K(-100.2%)$328.6 M(-1.9%)$334.8 M(+100.0%)$0.0-

TTM CFF

$328.0 M(-50.5%)$662.7 M(+0.0%)$662.7 M(-0.1%)$663.4 M(+98.1%)$334.8 M(+100.0%)$0.0-

Free Cash Flow

-$57.4 M(+2.8%)-$59.0 M(+19.4%)-$73.2 M(-35.0%)-$54.2 M(-61.5%)-$33.6 M(-41.4%)-$23.7 M-

TTM FCF

-$243.9 M(-10.8%)-$220.0 M(-19.1%)-$184.7 M(-65.7%)-$111.5 M(-94.6%)-$57.3 M(-141.4%)-$23.7 M-

CAPEX

-------

TTM CAPEX

-------

Dividends Paid

-------

TTM Dividends Paid

-------

TTM Dividend Per Share

-------

TTM Dividend Yield

-------

Payout Ratio

-------